Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

39
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
39
Atypical Pneumonia01:14

Atypical Pneumonia

37
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.1K
The pathophysiology of pneumonia involves the following steps:
4.1K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

69
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A rare case of urinary tuberculosis in a 14-year-old: Diagnosis and surgical management.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2026
Same author

Synovial fluid Lipocalin-2 as a biomarker for chronic prosthetic joint infection: Prospective validation in hip and knee revision arthroplasty.

Revista espanola de cirugia ortopedica y traumatologia·2026
Same author

Synovial fluid Lipocalin-2 as a biomarker for chronic prosthetic joint infection: Prospective validation in hip and knee revision arthroplasty.

Revista espanola de cirugia ortopedica y traumatologia·2026
Same author

Clinical Outcomes of Intra-Abdominal Candidiasis by Initial Antifungal Therapy.

Mycoses·2026
Same author

Cefepime/enmetazobactam for Gram-negative periprosthetic joint infections? A randomized porcine study on target tissue pharmacokinetics.

The Journal of antimicrobial chemotherapy·2026
Same author

Integrative transcriptomic and functional analyses reveal candidate transcription factors associated with sorghum grain quality.

Journal of experimental botany·2026
Same journal

Consensus-based evaluation of RIDASCREEN<sup>®</sup> TB ELISA compared with two interferon-gamma release assays in a low-incidence setting.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

A review of bloodstream infections-pathogens, pathogenesis, diagnostic strategies, treatment methods-challenges and future aspects.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Adaptive susceptibility shifts in Candidozyma auris following biocidal exposure: Exploratory effects on antifungal and biocidal susceptibility.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Prevalence and risk factors of sexually transmitted infections in women in eleven hospitals in two low-income countries: a cross-sectional study.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Tetracycline for Helicobacter pylori eradication: a narrative review from quadruple to dual therapy.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same journal

Breaking barriers: Implementation of a tuberculosis preventive treatment protocol among newly eligible populations with promising results.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.6K

Staphylococcus aureus bacteremic pneumonia.

C De la Calle1, L Morata2, N Cobos-Trigueros2

  • 1Department of Infectious Diseases Hospital Clínic, Barcelona, Spain. DELACALLE@CLINIC.UB.ES.

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|January 19, 2016
PubMed
Summary
This summary is machine-generated.

Staphylococcus aureus bacteremic pneumonia is a severe infection with a high mortality rate, often affecting patients with underlying health conditions. This study highlights the persistent high mortality and identifies risk factors for methicillin resistance.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
06:37

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source

Published on: February 7, 2013

17.2K

Related Experiment Videos

Last Updated: Mar 27, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.6K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source
06:37

Staphylococcus aureus Growth using Human Hemoglobin as an Iron Source

Published on: February 7, 2013

17.2K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Staphylococcus aureus bacteremic pneumonia is an uncommon but severe condition with scarce published data.
  • High mortality rates underscore the need for updated epidemiological and risk factor analysis.

Purpose of the Study:

  • To identify risk factors associated with methicillin resistance in Staphylococcus aureus bacteremic pneumonia.
  • To update the current mortality rates for this infection.

Main Methods:

  • Prospective collection of patients with S. aureus bacteremic pneumonia from 2000 to 2014.
  • Retrospective analysis to identify risk factors and compare outcomes between methicillin-susceptible (MSSA) and methicillin-resistant (MRSA) strains.

Main Results:

  • A total of 98 patients were included; 40.8% had community-acquired infections.
  • Frequent comorbidities included chronic lung disease, renal failure, diabetes, and cardiovascular disease.
  • Overall 30-day mortality was 46.9%. MRSA infections occurred in older patients with more cardiovascular disease and prior antibiotic exposure.

Conclusions:

  • Staphylococcus aureus bacteremic pneumonia remains a severe infection with high mortality, particularly in patients with comorbidities.
  • While MSSA infections presented with more septic shock, appropriate empirical antibiotic therapy was more common than for MRSA.
  • No significant difference in mortality was observed between MSSA and MRSA infections.